Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Mach

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Revue Medicale Suisse|September 30, 2011
[Anticancer drugs under pressure]A Ben Aïssa, A-C George, F Z El M'Rabet, et al.
Veterinary Journal (London, England : 1997)|January 27, 2020
Serum acylcarnitine profile in endurance horses with and without metabolic dysfunctionJ H van der Kolk, S Thomas, N Mach, et al.
Cancer Gene Therapy|May 14, 2011
Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapyF Schwenter, S Zarei, P Luy, et al.
Revue Medicale Suisse|June 20, 2014
[The Onco-hematology clinical research unit at the Geneva University Hospital: example of a fruitful public-private partners]M Ackermann-Zare, V Ancrenaz, N Blazek, et al.
Nature|March 24, 1998
Role for interleukin-3 in mast-cell and basophil development and in immunity to parasitesC S Lantz, J Boesiger, C H Song, et al.
Blood|February 3, 1998
Involvement of interleukin-3 in delayed-type hypersensitivityN Mach, C S Lantz, S J Galli, et al.
The New England Journal of Medicine|July 12, 1990
Fatal infection with a novel, unidentified mycobacterium in a man with the acquired immunodeficiency syndromeB Hirschel, H R Chang, N Mach, et al.
Meat Science|November 28, 2012
Surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry: a tool to predict pork qualityB Marcos, P Gou, M D Guàrdia, et al.
British Journal of Cancer|May 3, 2014
Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade gliomaA F Hottinger, A Ben Aissa, V Espeli, et al.
British Journal of Cancer|January 10, 2018
Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade gliomaA F Hottinger, A Ben Aissa, V Espeli, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Revue Medicale Suisse|September 30, 2011
[Anticancer drugs under pressure]A Ben Aïssa, A-C George, F Z El M'Rabet, et al.
Veterinary Journal (London, England : 1997)|January 27, 2020
Serum acylcarnitine profile in endurance horses with and without metabolic dysfunctionJ H van der Kolk, S Thomas, N Mach, et al.
Cancer Gene Therapy|May 14, 2011
Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapyF Schwenter, S Zarei, P Luy, et al.
Revue Medicale Suisse|June 20, 2014
[The Onco-hematology clinical research unit at the Geneva University Hospital: example of a fruitful public-private partners]M Ackermann-Zare, V Ancrenaz, N Blazek, et al.
Nature|March 24, 1998
Role for interleukin-3 in mast-cell and basophil development and in immunity to parasitesC S Lantz, J Boesiger, C H Song, et al.
Blood|February 3, 1998
Involvement of interleukin-3 in delayed-type hypersensitivityN Mach, C S Lantz, S J Galli, et al.
The New England Journal of Medicine|July 12, 1990
Fatal infection with a novel, unidentified mycobacterium in a man with the acquired immunodeficiency syndromeB Hirschel, H R Chang, N Mach, et al.
Meat Science|November 28, 2012
Surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry: a tool to predict pork qualityB Marcos, P Gou, M D Guàrdia, et al.
British Journal of Cancer|May 3, 2014
Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade gliomaA F Hottinger, A Ben Aissa, V Espeli, et al.
British Journal of Cancer|January 10, 2018
Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade gliomaA F Hottinger, A Ben Aissa, V Espeli, et al.
Pageof 4